Skip to content
healthcare.dev
Get a free key

Rylaze

NDC 68727-900, asparaginase erwinia chrysanthemi (recombinant)-rywn, injection, from Jazz Pharmaceuticals, Inc..

Product NDC
68727-900
Status
Listed
Labeler
Jazz Pharmaceuticals, Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761179
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68727-900 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASPARAGINASE20 mg/mL

Pharmacologic classes

Asparaginase [CS]; Asparagine-specific Enzyme [EPC]

Package NDCNDC-11Package
68727-900-03687270900033 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03) / .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/857e53aa-1098-4dad-b654-0276cdd43e03

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68727-900

Use it

Look up 68727-900 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68727-900 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68727-900. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.